Claims for Patent: 7,109,255

Summary for Patent: 7,109,255

Title:	Bioresorbable hydrogel compositions for implantable prostheses
Abstract:	Crosslinked compositions formed from water-insoluble copolymers are disclosed. These compositions are copolymers having a bioresorbable region, a hydrophilic region and at least two cross-linkable functional groups per polymer chain. Crosslinking of these polymers can be effected in solution in organic solvents or in solvent-free systems. If crosslinking occurs in a humid environment, a hydrogel will form. If crosslinking occurs in a non-humid environment, a xerogel will form which will form a hydrogel when exposed to a humid environment and the resulting crosslinked materials form hydrogels when exposed to humid environments. These hydrogels are useful as components in medical devices such as implantable prostheses. In addition, such hydrogels are useful as delivery vehicles for therapeutic agents and as scaffolding for tissue engineering applications.
Inventor(s):	Loomis; Gary L. (Morristown, NJ), Lentz; D. Christian (Pompton Plains, NJ)
Assignee:	Scimed Life Systems, Inc. (Maple Grove, MN)
Application Number:	10/928,431
Patent Claims:	1. A medical device having at least one surface coated with a bioresorbable coating composition; said coating composition comprising a water-insoluble copolymer comprising (1) a bioresorbable region; (2) a hydrophilic region; and (3) a plurality of cross-linkable functional groups per polymer chain. 2. The medical device of claim 1, wherein said medical device is a member selected from the group consisting of conduits, vascular grafts, textile materials, and polymeric films. 3. The medical device of claim 1, wherein said medical device comprises a polymer selected from the group consisting of olefin polymers, polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, fluorinated ethylene propylene copolymer, polyvinyl acetate, polystyrene, poly(ethylene terephthalate), polyurethane, polyurea, silicone rubbers, polyamides, polycarbonates, polyaldehydes, natural rubbers, polyester copolymer, styrene-butadiene copolymers, and combinations thereof. 4. The medical device of claim 1, wherein the medical device is a polytetrafluoroethylene vascular graft. 5. The medical device of claim 4, wherein said vascular graft has a luminal and an external surface; and said coating composition is in contact with said luminal surface. 6. The medical device of claim 5, wherein said coating composition includes at least one drug or bio-active agent. 7. The medical device of claim 6, wherein said drug or bio-active agent is dispersed throughout said coating composition. 8. The medical device of claim 6, wherein said coating composition provides a controlled release of the drug or bio-active agent. 9. The medical device of claim 8, wherein said drug or bio-active agent is selected from the group consisting of heparin, heparin sulfate, hirudin, chondroitin sulfate, dermatan sulfate, keratin sulfate, lytic agents, urokinase, streptokinase, penicillin, cephalosporins, vancomycins, aminoglycosides, quinolones, polymyxins, erythromycins, tetracyclines, chloramphenicols, clindamycins, lincomycins, sulfonamides, paclitaxel, docetaxel, alkylating agents, mechlorethamine, chlorambucil, cyclophosphamide, melphalan, ifosfamide, antimetabolites, methotrexate, 6-mercaptopurine, 5-fluorouracil, cytarabine, plant alkaloids, vinblastine, vincristine, etoposide, doxorubicin, daunomycin, bleomycin, mitomycin, nitrosureas, carmustine, lomustine, cisplatin, interferon, enzymes, asparaginase, tamoxifen, flutamide, amantadines, rimantadines, ribavirins, idoxuridines, vidarabines, trifluridines, acyclovirs, ganciclovirs, zidovudines, foscarnets, and combinations thereof. 10. A medical device comprising a vascular graft having at least one surface coated with a coating composition; said coating composition comprising a water-insoluble copolymer comprising (1) a bioresorbable region; (2) a hydrophilic region; and (3) a plurality of cross-linkable functional groups per polymer chain, and at least one drug or bioactive agent; said coating composition providing a controlled release of said drug or bioactive agent. 11. The medical device of claim 10, wherein said medical device comprises a polymer selected from the group consisting of olefin polymers, polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, fluorinated ethylene propylene copolymer, polyvinyl acetate, polystyrene, poly(ethylene terephthalate), polyurethane, polyurea, silicone rubbers, polyamides, polycarbonates, polyaldehydes, natural rubbers, polyester copolymer, styrene-butadiene copolymers, and combinations thereof. 12. The medical device of claim 10, wherein said vascular graft has a luminal and an external surface; and said coating composition is in contact with said luminal surface.

Details for Patent 7,109,255

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	01/16/1978		2017-08-18
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2017-08-18